Racura Oncology Ltd (ASX:RAC)
Australia · Delayed Price · Currency is AUD 2.380
+0.220 (10.19%)
At close: Mar 18, 2026
Racura Oncology Market Cap
Racura Oncology has a market cap or net worth of 432.54 million as of March 18, 2026. Its market cap has increased by 128.43% in one year.
Market Cap
432.54M
Enterprise Value
411.60M
Revenue
3.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.38
Market Cap Chart
Since July 13, 2016, Racura Oncology's market cap has increased from 12.64M to 432.54M, an increase of 3,322.77%. That is a compound annual growth rate of 44.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 392.56M | -20.48% |
| Dec 31, 2025 | 493.64M | 110.49% |
| Dec 31, 2024 | 234.51M | 70.76% |
| Dec 29, 2023 | 137.34M | -57.61% |
| Dec 30, 2022 | 324.00M | -43.55% |
| Dec 31, 2021 | 574.00M | 153.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuren Pharmaceuticals | 1.44B |
| PYC Therapeutics | 1.34B |
| Clarity Pharmaceuticals | 1.27B |
| Opthea | 738.77M |
| Clinuvel Pharmaceuticals | 489.46M |
| Tetratherix | 284.29M |
| Dimerix | 231.15M |
| Orthocell | 211.62M |